Back

HIV and cardiovascular risk: should we use other targets for cholesterol control? Brazilian data compared to major studies

2 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: HIV and cardiovascular disease (2) HIV and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mrs Ana Cristina De Souza Murta

Dante Pazzanese Institute of Cardiology and STI AIDS Reference Centre, Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
HIV is associated with subtle impairments in left ventricular function: insights from a large prospective cohort study of well-treated people with HIV
Doctor A. Reimer Jensen (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Thrombus aspiration in people living with HIV- a night mare for interventionist
Associate Professor H. Nataraj Setty (Bangalore, IN)
Abstract Slides Video
Presentation thumbnail
Pericoronary adipose tissue computed tomography attenuation (PCAT) as a marker of premature CVD in asymptomatic people living with HIV (PLWH) without traditional risk factors: H-ART to heart study
Doctor T. Wardill (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
The effect of HIV seropositivity on inpatient outcomes in atrial tachyarrhythmias: a US population analysis
Doctor J. Folkes (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Subclinical myocardial disfunction detected by left ventricle myocardial work impairment in patients with long standing human inmmunodeficiency virus infection
Mr R. Gascuena (Leganes, ES)
Abstract Slides Video

Access the full session

Session thumbnail
HIV and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of antiretroviral treatment on myocardial work and arterial function of treatment-naive patients with HIV
thumbnail
Congress Presentation
Residual inflammation in HIV and accelerated progression of coronary heart disease
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources